Owkin
Entry
2017
Hold
9yr
Status
Active
Who owns Owkin?
Owkin is a French Biotech company, currently owned by FRST Capital since 2017 and 2 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYMost recent investor
Cathay CapitalCathay Innovation Fund I · 2016 · VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2013 · present
Bpifrance InvestissementActive
2013 · present(13yr) · Large Venture · 2013 · Growth
Cathay CapitalActive
2017 · present(9yr) · Cathay Innovation Fund I · 2016 · VC
FRST CapitalActive
2017 · present(9yr) · Otium Venture · 2015 · VC
More from Cathay Innovation Fund I
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Owkin?
Owkin is currently owned by FRST Capital, Cathay Capital and 1 other, through Cathay Innovation Fund I, since 2017.
When did FRST Capital and 2 others acquire Owkin?
FRST Capital and 2 others acquired Owkin in 2017.
Who has owned Owkin over time?
Owkin has been through 3 private-equity ownership periods: Bpifrance Investissement · via Large Venture · since 2013; FRST Capital · via Otium Venture · since 2017; Cathay Capital · via Cathay Innovation Fund I · since 2017.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue